coronavirus drug

Anti-COVID drug developed by DRDO for emergency use gets approved

by
Anti-COVID drug developed by DRDO for emergency use gets approved

All the patients who were treated with this showed faster symptomatic cure compared to the Standard of Care (SoC) on various endpoints. An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS, a Defence Research and Development Organisation (DRDO), has along with Dr … Read more

Molnupiravir approval sought to target early stage COVID-19 cases: Natco vice chairman

by
Molnupiravir approval sought to target early stage COVID-19 cases: Natco vice chairman

Representative image After an outcry for remdesivir, there is now yet another experimental anti-viral drug – Molnupiravir to deal with COVID patients. Hyderabad-headquartered Natco Pharma on Monday, April 26th, disclosed to the bourses that it has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir … Read more